
Sign up to save your podcasts
Or


In this episode of Life Science Lab, host Ari Landon, PhD sits down with Christina Bodurow, PhD, Senior Vice President of Project Management at the Indiana Biosciences Research Institute (IBRI) and President-Elect of the American Chemical Society.
They discuss how project management helps teams define key questions, generate the right data, and make decisions that move scientific programs forward. Chris also shares insights on the foundational role of chemistry across life sciences and the importance of training and supporting the next generation of scientists.
About the Indiana Biosciences Research Institute
The Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to eliminate disease and improve human health and life. By connecting early-stage biotech companies with cutting-edge life science discoveries —and backed by the mission and resources of industry leaders, investors, and philanthropic partners— IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures.
Learn more about the IBRI here: https://www.indianabiosciences.org/
By Indiana Biosciences Research InstituteIn this episode of Life Science Lab, host Ari Landon, PhD sits down with Christina Bodurow, PhD, Senior Vice President of Project Management at the Indiana Biosciences Research Institute (IBRI) and President-Elect of the American Chemical Society.
They discuss how project management helps teams define key questions, generate the right data, and make decisions that move scientific programs forward. Chris also shares insights on the foundational role of chemistry across life sciences and the importance of training and supporting the next generation of scientists.
About the Indiana Biosciences Research Institute
The Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to eliminate disease and improve human health and life. By connecting early-stage biotech companies with cutting-edge life science discoveries —and backed by the mission and resources of industry leaders, investors, and philanthropic partners— IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures.
Learn more about the IBRI here: https://www.indianabiosciences.org/